Printer Friendly

ANALYST INTERVIEW: PHARMACEUTICALS: RODNEY SINGLETON - G.W. HENSSLER & ASSOC.

(RAD850) PHARMACEUTICALS: RODNEY SINGLETON - G.W. HENSSLER & ASSOC. Reviews the performance of the industry, and examines recent changes that have impacted companies in that sector. Topics discussed include competition, mergers and acquisitions, and the development of customer demand; and a number of companies are identified that are considered well positioned to succeed in the current market. Sector: Pharmaceuticals. Published date 8/26/02. Tickers featured: AMGN, BMY, FRX, IMCL, JNJ, LLY, MRK, MYL, PFE, PHA, SGP. Complete text approximately 3000 words. Document # RAD850.

ANALYST INTERVIEWS, The Wall Street Transcript, 67 Wall Street, NY 10005. Voice (212) 952 7433. Fax: (212) 668-9842. E-mail: transcript@twst.com.

***
COPYRIGHT 2002 Wall Street Transcript Corporation
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Comment:ANALYST INTERVIEW: PHARMACEUTICALS: RODNEY SINGLETON - G.W. HENSSLER & ASSOC.
Publication:Wall Street Transcript Digest
Article Type:Brief Article
Geographic Code:1USA
Date:Aug 26, 2002
Words:105
Previous Article:ANALYST INTERVIEW: PAPER & FOREST PRODUCTS: DON BROWN - PRINCIPAL CAPITAL MANAGEMENT.
Next Article:MONEY MANAGER INTERVIEW: MOTTER/JOURNEAY/GRACE JR. - CHILTON CAPITAL MANAGEMENT LP.
Topics:


Related Articles
MONEY MANAGER INTERVIEW: THEODORE PARRISH - G.W. HENSSLER & ASSOCIATES LTD.
Market upswing: portfolio manager Ted Parrish is banking on financial and healthcare sectors for long-term growth.
One bad apple: Theodore Parrish's portfolio of A-rated companies had a minor flaw.

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |